Opportunity Information: Apply for PAR 13 080
Apply for PAR 13 080
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs 93.399 Cancer Control.
- This funding opportunity was created on Jan 9, 2013 and posted on Jan 9, 2013.
- Applicants must submit their applications by Jan 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: City or township governments Special district governments County governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Public housing authorities/Indian housing authorities Small businesses For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH grant opportunity "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)" (Funding Opportunity Number PAR-13-080) supports research projects that make novel, rigorous use of data that already exist rather than collecting entirely new datasets. The core idea is to speed progress in drug abuse and addiction research by encouraging investigators to extract additional scientific value from previously collected social science, behavioral, administrative, clinical, and neuroimaging data. The FOA explicitly defines "drug using behaviors" broadly, covering alcohol, tobacco, prescription drugs, and other drugs, and it also highlights closely related public health concerns such as HIV risk behaviors, prevention of drug use and HIV, and patterns of health service utilization.
The scientific scope centers on understanding both etiology and epidemiology: why drug use begins and escalates, how it unfolds over time, and what consequences follow for individuals and communities. Applications are expected to address trajectories of substance use and related disorders, including factors that increase risk or promote resilience, and how these pathways intersect with psychopathology and other health outcomes. Beyond describing patterns, the FOA encourages analyses that can inform practical strategies for prevention and treatment, including how high-quality and cost-effective services can be developed, tested, implemented, and delivered in real-world settings. Because the announcement is focused on innovative analysis, strong proposals typically emphasize new analytic approaches, creative linkage of datasets, underused measures within existing datasets, or questions that could not be answered when the data were first collected.
A notable feature of this FOA is that it is a reissue of PAR-10-018 but broadened to include additional data modalities, especially neuroimaging data. This expansion is meant to make it easier for researchers to use imaging data that may be housed at the original collecting institution or stored in third-party repositories. In practice, that means the program is open to projects that integrate brain-based measures with behavioral, social, or administrative information, as long as the work is grounded in the study of substance use, addiction-related outcomes, and associated HIV risk and prevention topics.
The opportunity is offered as an NIH R01 research project grant, under a discretionary grant mechanism, and is sponsored by multiple NIH partners: the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Cancer Institute (NCI), and the Office of Behavioral and Social Sciences Research (OBSSR). This mix of institutes signals an interest in substance use across multiple domains, including alcohol-specific and tobacco/cancer-relevant questions, as well as broader behavioral and social science perspectives.
From an administrative standpoint, the FOA was posted January 9, 2013, with an original and final closing date of January 7, 2016, and an archive date of February 7, 2016. The listing includes an award ceiling of $150,000 and indicates there is no cost-sharing or matching requirement. It is cataloged under CFDA program numbers 93.273 (Alcohol Research Programs), 93.279 (Drug Abuse and Addiction Research Programs), and 93.399 (Cancer Control).
Eligibility is intentionally broad. Applicants may include various levels of government (state, county, city/township), special district governments, tribal governments and tribal organizations, public and private institutions of higher education, independent school districts, public housing authorities/Indian housing authorities, nonprofits (both 501(c)(3) and certain non-501(c)(3) entities), small businesses, and for-profit organizations. The FOA also explicitly includes many institution types and community-based organizations such as HBCUs, Hispanic-serving institutions, AANAPISIs, tribally controlled colleges and universities, faith-based or community-based organizations, and eligible federal agencies. Foreign organizations and foreign institutions are eligible, and foreign components of U.S. organizations are allowed, consistent with NIH policy. Overall, the eligibility language is designed to encourage a wide range of research teams, including those with specialized access to existing datasets or unique analytic expertise, to contribute to the evidence base on substance use, addiction, HIV risk, and service delivery.
Frequently Asked Questions (FAQs)
What is the name and funding opportunity number of this NIH grant?
The opportunity is titled "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)" and the Funding Opportunity Number is PAR-13-080.
What is the main purpose of this funding opportunity?
The purpose is to accelerate progress in drug abuse and addiction research by supporting research projects that make novel, rigorous use of data that already exist, rather than collecting entirely new datasets.
What type of grant mechanism is used?
This opportunity uses the NIH R01 Research Project Grant mechanism and is described as a discretionary grant mechanism.
What kinds of data does the FOA encourage applicants to use?
The FOA encourages innovative analyses of previously collected data, including social science, behavioral, administrative, clinical, and neuroimaging data.
Does this opportunity fund projects that collect brand-new datasets?
The core idea is to support projects that extract additional scientific value from existing data rather than collecting entirely new datasets.
How broadly does the FOA define "drug using behaviors"?
The FOA defines drug using behaviors broadly, explicitly including alcohol, tobacco, prescription drugs, and other drugs.
Are HIV-related topics within scope?
Yes. The FOA highlights closely related public health concerns such as HIV risk behaviors, prevention of drug use and HIV, and patterns of health service utilization.
What scientific themes or research questions are emphasized?
The scientific scope centers on etiology and epidemiology, including why drug use begins and escalates, how it unfolds over time, and what consequences follow for individuals and communities.
Are studies on substance use trajectories and related disorders encouraged?
Yes. Applications are expected to address trajectories of substance use and related disorders, including factors that increase risk or promote resilience, and how these pathways intersect with psychopathology and other health outcomes.
Does the FOA encourage research that informs prevention and treatment?
Yes. Beyond describing patterns, the FOA encourages analyses that can inform practical strategies for prevention and treatment, including how high-quality and cost-effective services can be developed, tested, implemented, and delivered in real-world settings.
What makes a proposal "strong" under this FOA?
Because the announcement is focused on innovative analysis, strong proposals typically emphasize new analytic approaches, creative linkage of datasets, underused measures within existing datasets, or questions that could not be answered when the data were first collected.
Is neuroimaging data specifically included in this reissued FOA?
Yes. This FOA is a reissue of PAR-10-018 but was broadened to include additional data modalities, especially neuroimaging data.
Where might the neuroimaging data be located?
The FOA notes that imaging data may be housed at the original collecting institution or stored in third-party repositories.
Can projects integrate neuroimaging with other kinds of data?
Yes. The program is open to projects that integrate brain-based measures with behavioral, social, or administrative information, as long as the work is grounded in substance use, addiction-related outcomes, and associated HIV risk and prevention topics.
Which NIH organizations sponsor this opportunity?
The opportunity is sponsored by multiple NIH partners: the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Cancer Institute (NCI), and the Office of Behavioral and Social Sciences Research (OBSSR).
What does the mix of NIH sponsors suggest about the intended research areas?
The mix signals interest in substance use across multiple domains, including alcohol-specific and tobacco/cancer-relevant questions, as well as broader behavioral and social science perspectives.
When was the FOA posted, and what were the closing dates?
The FOA was posted on January 9, 2013. The original and final closing date was January 7, 2016.
When was the FOA archived?
The archive date listed is February 7, 2016.
Is there an award ceiling listed for this opportunity?
Yes. The listing includes an award ceiling of $150,000.
Is cost sharing or matching required?
No. The listing indicates there is no cost-sharing or matching requirement.
What CFDA program numbers are associated with this FOA?
The opportunity is cataloged under CFDA program numbers 93.273 (Alcohol Research Programs), 93.279 (Drug Abuse and Addiction Research Programs), and 93.399 (Cancer Control).
Who is eligible to apply?
Eligibility is intentionally broad and includes various levels of government (state, county, city/township), special district governments, tribal governments and tribal organizations, public and private institutions of higher education, independent school districts, public housing authorities/Indian housing authorities, nonprofits (both 501(c)(3) and certain non-501(c)(3) entities), small businesses, and for-profit organizations.
Are community-based and minority-serving institutions included in the eligibility language?
Yes. The FOA explicitly includes many institution types and community-based organizations such as HBCUs, Hispanic-serving institutions, AANAPISIs, tribally controlled colleges and universities, and faith-based or community-based organizations.
Are federal agencies eligible?
Yes. Eligible federal agencies are included in the eligibility language.
Are foreign organizations eligible to apply?
Yes. Foreign organizations and foreign institutions are eligible, consistent with NIH policy.
Are foreign components of U.S. organizations allowed?
Yes. Foreign components of U.S. organizations are allowed, consistent with NIH policy.
Why does the FOA emphasize broad eligibility?
The eligibility language is designed to encourage a wide range of research teams, including those with specialized access to existing datasets or unique analytic expertise, to contribute to the evidence base on substance use, addiction, HIV risk, and service delivery.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Life Course Research Network
Previous opportunity: Indoor Environment of Low Income Renovated Multifamily Housing in the Western Region of the United States
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 080
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 080) also looked into and applied for these:
| Funding Opportunity |
|---|
| Bridging the Gap Between Cancer Mechanism and Population Science (U01) Apply for PAR 13 081 Funding Number: PAR 13 081 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Research Education Program for Clinical Researchers and Clinicians (R25) Apply for PAR 13 084 Funding Number: PAR 13 084 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Apply for PAR 13 086 Funding Number: PAR 13 086 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) Apply for PAR 13 087 Funding Number: PAR 13 087 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Planning for a National Center for Particle Beam Radiation Therapy Research (P20) Apply for PAR 13 096 Funding Number: PAR 13 096 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| NCI Experimental Therapeutics Clinical Trials Network with Phase 1 Emphasis (ET CTN) (UM1) Apply for RFA CA 13 006 Funding Number: RFA CA 13 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $850,000 |
| The Influence of the Microbiome on Preterm Labor and Delivery (R01) Apply for RFA NR 13 002 Funding Number: RFA NR 13 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| The Influence of the Microbiome on Preterm Labor and Delivery (R21) Apply for RFA NR 13 003 Funding Number: RFA NR 13 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Collaborative Human Tissue Network (CHTN) (UM1) Apply for RFA CA 13 007 Funding Number: RFA CA 13 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,200,000 |
| Research on Marijuana Legalization in the US (Admin Supp) Apply for PA 13 138 Funding Number: PA 13 138 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Lasker Clinical Research Scholars Program (Si2) Apply for RFA OD 13 004 Funding Number: RFA OD 13 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Multicenter AIDS Cohort Study Center for the Coordination, Analysis, and Management of the MACS (CAMACS)(UM1) Apply for RFA AI 13 010 Funding Number: RFA AI 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,400,000 |
| Limited Competition Multicenter AIDS Cohort Study (MACS) Clinical Research Sites (U01) Apply for RFA AI 13 011 Funding Number: RFA AI 13 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $4,200,000 |
| Limited Competition Scholars Training for the Advancement of Research (STAR) Revision to NINR T32 Training Grants (T32) Apply for RFA NR 13 010 Funding Number: RFA NR 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Apply for PAR 13 146 Funding Number: PAR 13 146 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Exceptional Research on HIV/AIDS (R01) Apply for RFA DA 14 003 Funding Number: RFA DA 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PA 13 157 Funding Number: PA 13 157 Agency: National Institutes of Health Category: Education Health Funding Amount: $175,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21/R33) Apply for PAR 13 158 Funding Number: PAR 13 158 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 13 163 Funding Number: PAR 13 163 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R01) Apply for PA 13 165 Funding Number: PA 13 165 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 080", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.